Metabolic comorbidities and medical institution utilization among breast cancer survivors: a national population-based study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: We investigated metabolic comorbidity status and patterns of medical institution utilization among breast cancer survivors using medical claims data from the Health Insurance Review and Assessment Service (HIRA). Methods: Using claims data obtained from the HIRA, we selected breast cancer survivors between 2010 and 2015. Descriptive statistics were calculated to determine the frequency of metabolic comorbidities, as well as to analyze patterns of medical institution utilization in accordance with disease status. Results: A total of 89,953 breast cancer survivors were identified. Among these, 12,364 (13.7%) had hypercholesterolemia, 20,754 (23.1%) had hypertension (HTN), and 11,102 (12.3%) had diabetes mellitus (DM). In particular, more than half of breast cancer survivors older than 60 years had HTN, and other diseases sharply increased beginning at age 50 years. For HTN, a total of 531,292 claims were submitted; more than 80% (n = 473,737) were from primary medical institutions, whereas only 2.4% (n = 12,551) were from tertiary medical institutions. The number of claims submitted for DM was 231,526; those from primary medical institutions accounted for 68.5% (n = 158,566), whereas claims from tertiary medical institutions accounted for 12.0% (n = 27,693). In subgroup analyses, the utilization of secondary and tertiary medical institutions was higher among patients with severe diseases and those diagnosed following their breast cancer diagnosis. Conclusions: More than 10% of breast cancer survivors were diagnosed with a metabolic comorbidity. Through analysis of medical institution utilization patterns, we ascertained that a communication system linking secondary and tertiary medical institutions with primary medical institutions is needed.
Abstract
Background/Aims: We investigated metabolic comorbidity status and patterns of medical institution utilization among breast cancer survivors using medical claims data from the Health Insurance Review and Assessment Service (HIRA). Methods: Using claims data obtained from the HIRA, we selected breast cancer survivors between 2010 and 2015. Descriptive statistics were calculated to determine the frequency of metabolic comorbidities, as well as to analyze patterns of medical institution utilization in accordance with disease status. Results: A total of 89,953 breast cancer survivors were identified. Among these, 12,364 (13.7%) had hypercholesterolemia, 20,754 (23.1%) had hypertension (HTN), and 11,102 (12.3%) had diabetes mellitus (DM). In particular, more than half of breast cancer survivors older than 60 years had HTN, and other diseases sharply increased beginning at age 50 years. For HTN, a total of 531,292 claims were submitted; more than 80% (n = 473,737) were from primary medical institutions, whereas only 2.4% (n = 12,551) were from tertiary medical institutions. The number of claims submitted for DM was 231,526; those from primary medical institutions accounted for 68.5% (n = 158,566), whereas claims from tertiary medical institutions accounted for 12.0% (n = 27,693). In subgroup analyses, the utilization of secondary and tertiary medical institutions was higher among patients with severe diseases and those diagnosed following their breast cancer diagnosis. Conclusions: More than 10% of breast cancer survivors were diagnosed with a metabolic comorbidity. Through analysis of medical institution utilization patterns, we ascertained that a communication system linking secondary and tertiary medical institutions with primary medical institutions is needed.
참고문헌 (27)
- Siegel RL, "Cancer statistics, 2016", CA Cancer J Clin, 66, pp.7~30 (2016)
- Arrington AK, "Life expectancy after curative-intent treatment of breast cancer : impact on long-term follow-up care", Am Surg, 80, pp.604~609 (2014)
- 오창모, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013", Cancer Research and Treatment, 48(2), pp.436~450 (2016), 대한암학회
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011", Cancer Research and Treatment, 46(2), pp.109~123 (2014), 대한암학회
- DeSantis CE, "Cancer treatment and survivorship statistics, 2014", CA Cancer J Clin, 64, pp.252~271 (2014)
- 이지은, "One-Year Experience Managing a Cancer Survivorship Clinic Using a Shared-Care Model for Gastric Cancer Survivors in Korea", Journal of Korean Medical Science, 31(6), pp.859~865 (2016), 대한의학회
- Peairs KS, "Diabetes mellitus and breast cancer outcomes : a systematic review and meta-analysis", J Clin Oncol, 29, pp.40~46 (2011)
- Goon PK, "Hypertension and breast cancer : an association revisited", J Hum Hypertens, 20, pp.722~724 (2006)
- Nelson ER, "27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology", Science, 342, pp.1094~1098 (2013)
- Hickish T, "Glucose intolerance during adjuvant chemotherapy for breast cancer", J Natl Cancer Inst, 101, pp.537~ (2009)
- Redig AJ, "Care of the cancer survivor : metabolic syndrome after hormone-modifying therapy", Am J Med, 123, pp.87~ (2010)
- Chen WW, "The impact of diabetes mellitus on prognosis of early breast cancer in Asia", Oncologist, 17, pp.485~491 (2012)
- Tang Z, "Associations between diabetes and quality of life among breast cancer survivors", PLoS One, 11, pp.e0157791~ (2016)
- Earle CC, "Under use of necessary care among cancer survivors", Cancer, 101, pp.1712~1719 (2004)
- Shin DW, "Antihypertensive medication adherence in cancer survivors and its affecting factors : results of a Korean population-based study", Support Care Cancer, 19, pp.211~220 (2010)
- Shin JY, "Comparison of diabetes management status between cancer survivors and the general population : results from a Korean population-based survey", PLoS One, 9, pp.e110412~ (2014)
- Evaluation of Appropriateness of Medical Care Benefits for Diabetes Mellitus, "Health Insurance Review and Assessment Service", HIRA, ~ (2016)
- Evaluation of Appropriateness of Medical Care Benefits for Hypertension, "Health Insurance Review and Assessment Service", HIRA, ~ (2016)
- Shao S, "Diabetes and overall survival among breast cancer patients in the U. S. military health system", Cancer Epidemiol Biomarkers Prev, 27, pp.50~57 (2018)
- Oudin C, "Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia", Blood, 117, pp.4442~4448 (2011)
- Youlden DR, "Incidence and mortality of female breast cancer in the Asia-Pacific region", Cancer Biol Med, 11, pp.101~115 (2014)
- Rettig SM, "Medication regimen complexity in patients with uncontrolled hypertension and", or diabetes, 2013, pp.53, 427~431
- Armstrong DG, "Diabetic foot ulcers and vascular insufficiency : our population has changed, but our methods have not", J Diabetes Sci Technol, 5, pp.1591~1595 (2011)
- 이진용, "Evidence of a Broken Healthcare Delivery System in Korea: Unnecessary Hospital Outpatient Utilization among Patients with a Single Chronic Disease Without Complications", Journal of Korean Medical Science, 29(12), pp.1590~1596 (2014), 대한의학회
- Oeffinger KC, "Models for delivering survivorship care", J Clin Oncol, 24, pp.5117~5124 (2006)
- Shin DW, "Oncologists experience with second primary cancer screening : current practices and barriers and potential solutions", Asian Pac J Cancer Prev, 13, pp.671~676 (2012)
- Walsh J, "What are the current barriers to effective cancer care coordination? A qualitative study", BMC Health Serv Res, 10, pp.132~ (2010)